178 related articles for article (PubMed ID: 3409231)
1. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients.
Mickel RA; Kessler DJ; Taylor JM; Lichtenstein A
Cancer Res; 1988 Sep; 48(17):5017-22. PubMed ID: 3409231
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
3. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
[TBL] [Abstract][Full Text] [Related]
4. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.
Mukhopadhyaya R; Tatake RJ; Krishnan N; Rao RS; Fakih AR; Naik SL; Gangal SG
J Clin Lab Immunol; 1989 Sep; 30(1):21-5. PubMed ID: 2641790
[TBL] [Abstract][Full Text] [Related]
7. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
Saxon A; Portaro J
Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
[TBL] [Abstract][Full Text] [Related]
8. Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease.
Ruco LP; Procopio A; Uccini S; Marcorelli E; Baroni CD
Cancer Res; 1982 May; 42(5):2063-8. PubMed ID: 6175405
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell activity in the perigastric lymph nodes from patients with gastric carcinoma or benign lesions.
Koba F; Akiyoshi T; Tsuji H
J Clin Lab Immunol; 1987 Aug; 23(4):191-5. PubMed ID: 2959787
[TBL] [Abstract][Full Text] [Related]
10. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
11. Depressed natural killer cell activity in cervical lymph nodes containing focal metastatic squamous cell carcinoma.
Kessler DJ; Mickel RA; Lichtenstein A
Arch Otolaryngol Head Neck Surg; 1988 Mar; 114(3):313-8. PubMed ID: 3342125
[TBL] [Abstract][Full Text] [Related]
12. Functional and phenotypic analysis of lymphocytes in head and neck cancer.
Snyderman CH; Heo DS; Johnson JT; D'Amico F; Barnes L; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1991 Aug; 117(8):899-905. PubMed ID: 1832546
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of natural killer cell function and risk of metastatic poorly differentiated head and neck cancer.
Schantz SP; Ordonez NG
Nat Immun Cell Growth Regul; 1991; 10(5):278-88. PubMed ID: 1758468
[TBL] [Abstract][Full Text] [Related]
14. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis.
Takeuchi H; Maehara Y; Tokunaga E; Koga T; Kakeji Y; Sugimachi K
Am J Gastroenterol; 2001 Feb; 96(2):574-8. PubMed ID: 11232710
[TBL] [Abstract][Full Text] [Related]
16. Neck node immunoreactivity in head and neck carcinoma.
Mandell-Brown M; Johnson JT; Rabin BS; Hamill E; Wagner RL
Otolaryngol Head Neck Surg; 1986 Nov; 95(4):500-6. PubMed ID: 2952933
[TBL] [Abstract][Full Text] [Related]
17. Modulation of NK activity in regional lymph nodes by preoperative immunotherapy with OK-432 in patients with cancer of the oral cavity.
Vinzenz K; Matejka M; Watzek G; Porteder H; Neuhold N; Micksche M
Cancer Detect Prev Suppl; 1987; 1():463-75. PubMed ID: 3480060
[TBL] [Abstract][Full Text] [Related]
18. Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.
Saxon A; Portis J
Cancer Res; 1977 Apr; 37(4):1154-8. PubMed ID: 300279
[TBL] [Abstract][Full Text] [Related]
19. Suppression of natural killer cell activity by serum derived from head and neck cancer patients.
Kumazawa H; Minamino M; Yukawa N; Hess M
Cancer Detect Prev; 1995; 19(6):494-502. PubMed ID: 8925518
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features and inhibitory activity of regional lymph node cells on the cytotoxicity of autologous killer cells in patients with primary lung cancer].
Kadoyama C; Kimura H; Yamaguchi Y
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2906-11. PubMed ID: 2959205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
